Trial Identifier: | D5980R00033 |
Sponsor: | AstraZeneca |
NCTID:: | NCT05219630 |
Start Date: | May 2022 |
Primary Completion Date: | June 2023 |
Study Completion Date: | June 2023 |
Condition: | Chronic Obstructive Pulmonary Disease (COPD) |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
Japan, Aichi | Nagoya, Aichi, Japan, Nagoya |
Japan, Aichi | Seto, Aichi, Japan, Seto |
Japan, Ehime | Toon, Ehime, Japan, Toon |
Japan, Fukui | Fukui, Japan, Fukui |
Japan, Fukuoka | Fukuoka, Japan, Fukuoka |
Japan, Fukuoka | Kurume, Fukuoka, Japan, Kurume |
Japan, Hiroshima | Hiroshima, Japan, Hiroshima |
Japan, Ibaraki | Tsuchiura, Ibaraki, Japan, Tsuchiura |
Japan, Ishikawa | Kanazawa, Ishikawa, Japan, Kanazawa |
Japan, Kagawa | Takamatsu, Kagawa, Japan, Takamatsu |
Japan, Kagoshima | Kagoshima, Japan, Kagoshima |
Japan, Mie | Matsuzaka, Mie, Japan, Matsuzaka |
Japan, Miyazaki | Miyazaki, Japan, Miyazaki |
Japan, Nara | Kashihara, Nara, Japan, Kashihara |
Japan, Oita | Oita, Japan, Oita |
Japan, Osaka | Osaka, Japan, Osaka |
Japan, Tokyo | Chuo, Tokyo, Japan, Chuo |